[Form 4] Veracyte, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Rebecca Chambers, Chief Financial Officer of Veracyte, Inc. (VCYT), reported a Form 4 disclosing that on 09/02/2025 5,371 shares of Common Stock were withheld to satisfy tax withholding obligations related to the vesting of restricted stock units. The filing shows 133,158 shares of Common Stock beneficially owned by the reporting person after the transaction. The transaction code is noted as F and the per-share price listed is $30.11, with the filer confirming the withholding was not a sale but a tax-related retention of shares.

Insights

Financial Analyst

Routine tax-withholding on RSU vesting; no sale, modest ownership change.

The Form 4 documents a standard tax-withholding event where 5,371 vested RSU shares were withheld rather than sold. This does not reflect a market disposition of shares and therefore is typically neutral for immediate valuation impact. The CFO retained a total beneficial ownership of 133,158 shares after withholding, which remains a quantifiable insider stake but no material change in control or dilution is indicated by this single event.

Corporate Governance Expert

Disclosure aligns with Section 16 reporting; procedural rather than strategic.

The filing meets Section 16(a) requirements by reporting the withholding to satisfy tax obligations on vested RSUs. The explicit remark that the transaction "does not represent a sale" clarifies intent and reduces potential governance concerns about opportunistic insider selling. No additional governance issues or exemptions are evident from the information provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chambers Rebecca

(Last) (First) (Middle)

6000 SHORELINE COURT

SUITE 300

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2025		F(1)		5,371	D	$30.11	133,158	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale.

Remarks:

	/s/ Jonathan Wygant as attorney-in-fact	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Rebecca Chambers report on the Form 4 for VCYT?

The filing reports that 5,371 shares were withheld to satisfy tax withholding on vested restricted stock units on 09/02/2025.

Does the Form 4 transaction represent a sale of VCYT shares?

No. The filer explicitly states the withholding "does not represent a sale" but reflects shares withheld for tax obligations.

How many VCYT shares does the reporting person beneficially own after the transaction?

The Form 4 shows 133,158 shares beneficially owned following the reported transaction.

What price per share is listed on the Form 4 for the withheld VCYT shares?

The per-share amount associated with the transaction is listed as $30.11.

Who filed the Form 4 on behalf of the reporting person?

The signature block shows the form was executed by /s/ Jonathan Wygant as attorney-in-fact on 09/04/2025.